NHS to begin controversial Chemical Castration Studies on Gay Children as result of Transgender Lobby


Transgender activists have successfully lobbied the UK government to fund chemical castration studies on twelve year old lesbian and gay children. In a stunning success for transgender lobbyists the NHS this week approved medical experiments which will chemically castrate gay children in attempt to correct gender-nonconformity. The children have all been referred for psychiatric treatment due to non-compliance with sex-based gender stereotypes. The large majority of these “feminine male” and “masculine female” children are not transgender, but homosexual. The experiment is designed to test the effects of powerful sterilization drugs on gay children, preventing natural puberty from occurring. Trans activists say this is important because it will increase the attractiveness and gender-conformity of a tiny minority of these children who may be transgender, by preventing natural puberty from ever occurring. They claim that the long term physiological and psychological effects on the predominately gay and lesbian kids are acceptable casualties for such an outcome.
From the Mirror: “The controversial treatment halts puberty, stunting sex organs and preventing the growth of facial hair and sperm in boys, and breasts in girls.
The injections, previously available only to over-15s with gender identity disorder, are being made available to younger people under an NHS study after pressure from families and doctors.
Doctors admit most children with the problem do not go on to have a sex change, often turning out to be  gay.”
The experiment will follow the effects of stunted sex organs on gay children. It is expected to cause atrophy of sexual organs and gonads, eliminating hormone production, causing cessation of menstruation, halting sperm production, stopping bone growth (and height/growth spurt), decreasing bone density (leading to possible osteoporosis), preventing normal body fat distribution, interrupting natural insulin resistance and other unknown effects, some of which will not become apparent until years after the gay children are exposed. It will also track the psychological and social effects of preventing children from undergoing natural puberty at the appropriate age and the elimination of the onset of normal adolescent sexual desire. Since the vast majority of children referred with gender compliance issues or GID = Gender Identity Disorder become asymptomatic in adulthood (and largely homosexual) the studies will also test whether GID symptoms will be prolonged with treatment.
Transgender lobbyists claim that male transsexuals have a harder time “passing” as female if they are allowed to undergo natural puberty and then desire sex change surgery as adults, and that 1 to 10% of these children may turn out to be male transsexuals in adulthood. The psychological and health effects of chemical castration on the majority non-transsexual children are considered an acceptable price for the increased future “attractiveness” of the tiny minority of the boy research subjects who may wish to adopt transsexuality and “pass” as female as adults. The tiny minority of females who may grow up to be transsexual will partially “pass better” as male because breast growth will be halted, but aborted bone growth will cause decreased height causing them to be shorter than most females.
Studies on children seeking treatment for GID (a psychiatric diagnosis introduced in 1980) before these chemical castration experiments are scant. According to the overview of research in Current Problems Adolescent Health Care 2009 “GID in Children and Adolescents”:

“The studies clearly show that the majority of children

with gender dysphoria will not remain gender
dysphoric after puberty. Children with extreme gender
dysphoria or GID are more likely to have persistent
GID than children whose behavior and cross-gender
identification is weaker or less persistent. Concerning
sexual orientation, there is a strong linkage between
GID in childhood and later homosexual orientation or
bisexuality, as most children with GID later become
homosexual. It should be noted that there are no
reliable predictors of continuing GID or gender dysphoria.”
“One could argue that,
from the point of view of psychosexual development,
in early adolescence, a teenager’s clarification about
his or her own orientation in sexual desires and
fantasies should precede any fixed identification with a
prospective adult gender role. As puberty-delaying
hormones are suppressing libidinal impulses, this process
of clarification about libidinal object orientation is
likely to be inhibited, too. Other arguments against
early hormone treatment are that the effects of puberty-
delaying hormones on brain development are not
yet known, that the children are too young to make a
decision of such far-reaching consequences, and that
many children with GID have serious comorbidity or
live in extremely adverse life circumstances.
The majority of children outgrow their wish to change sex and gender.”
From “Gender identity disorders in childhood and adolescence: currently debated concepts and treatment strategies” (2008):
” Gender identity disorders (GID) can appear even in early infancy with a variable degree of severity. Their prevalence in childhood and adolescence is below 1%. GID are often associated with emotional and behavioral problems as well as a high rate of psychiatric comorbidity. Their clinical course is highly variable. There is controversy at present over theoretical explanations of the causes of GID and over treatment approaches, particularly with respect to early hormonal intervention strategies.
As there have been no large studies to date on the course of GID, and, in particular, no studies focusing on causal factors for GID, the evidence level for the various etiological models that have been proposed is generally low. Most models of these disorders assume that they result from a complex biopsychosocial interaction. Only 2.5% to 20% of all cases of GID in childhood and adolescence are the initial manifestation of irreversible transsexualism. The current state of research on this subject does not allow any valid diagnostic parameters to be identified with which one could reliably predict whether the manifestations of GID will persist, i.e., whether transsexualism will develop with certainty or, at least, a high degree of probability.
CONCLUSIONS: The types of modulating influences that are known from the fields of developmental psychology and family dynamics have therapeutic implications for GID. As children with GID only rarely go on to have permanent transsexualism, irreversible physical interventions are clearly not indicated until after the individual’s psychosexual development is complete. The identity-creating experiences of this phase of development should not be restricted by the use of LHRH analogues that prevent puberty.”
An upcoming conference of The Royal College of Physicians Lesbian and Gay Interest Group “Transgender:Time To Change” is scheduled to address lesbian, gay, and gender issues in psychiatry. Transgender activists are planning to protest the discussion, another chapter in the increasingly adversarial rift between lesbian/gay and transgender political, social and activist agendas.